Halberd Corp (HALB)

[EHRjunkie]

For me the R&D-contract with Arizona State University (ranked no. 1 in research) took away whatever questions/doubt I had:

https://halberdcorporation.com/wp-content/uploads/2020/09/ASU-K-Fully-Executed.pdf

The principal investigator at ASU for HALB's R&D is Prof. Dr. Qiang (Shawn) Chen (see page 3 Exhibit A of R&D-contract):

https://sols.asu.edu/qiang-chen

Take a look at his research projects, patents etc.

Halberd (through exclusive license MARV enterprises) has its IP fully protected by 3 granted US patents and 16 provisional patent applications.

Halberd is very close to reach full proof-of-concept eradicating the building blocks (Tau, B-amyloid, Ph-Tau) and inflammatory cytokines related to some of the most debilitating neurodegenerative diseases, like Alzheimer's, PTSD, TBI, ALS, MS etc.

Yesterdays PR about the SAMS contract was nice, but especially because it's an indication for what's to come: a contract with DARPA (military) to start animal testing.

Catalysts for the very near term:
- more updates about eradicating GLUTAMATE, IL-4, Tau and B-amyloid from CSF
- up-list to OTCQB (almost ready)
- with full PoC Halberd will try to find partner (DARPA)
- attract funding / government grant
- start animal testing and if successful human testing

Until now NO big pharma company has been successful in treating/curing neurodegenerative diseases, for the very simple reason that medicine CANNOT pass the blood-brain-barrier. Halberd's treatment is based on treating blood/CSF outside the body and then returning it after eradicating the pathogens. IF it works we're looking at a multi-billion dollar company. IF not it's a total loss. Big risk, high reward. Do your DD. Good luck